HR 8529
116th Congress
House
Health
Home and outpatient care
Inflation and prices
Medicaid
Prescription drugs
State and local government operations
Protecting Access to Affordable Medicines Act of 2020
Everywhere this bill has been
2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Oct 6, 2020
Referred to the House Committee on Energy and Commerce.
Oct 6, 2020
Introduced in House
Ask about this bill
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Plain-English summary
Protecting Access to Affordable Medicines Act of 2020
This bill prohibits additional rebates for certain drugs under the Medicaid Drug Rebate Program. Specifically, the bill prohibits additional rebates with respect to noninnovator multiple-source drugs (i.e., generics) for which the average manufacturer price is less than $1.
What's happening now
Referred to the House Committee on Energy and Commerce.
Bill text
1 version
- Introduced in House Formatted Text PDF Formatted XML
Committees of jurisdiction
1
Cosponsors
5
Cite this page
U.S. Congress. (2026). H.R. 8529: Protecting Access to Affordable Medicines Act of 2020. 116th Congress. Open America. https://openamerica.io/bill/116-HR-8529/
"H.R. 8529: Protecting Access to Affordable Medicines Act of 2020." 116th Congress, 2026, Open America, https://openamerica.io/bill/116-HR-8529/.
H.R. 8529, 116th Cong. (2026), https://openamerica.io/bill/116-HR-8529/.
[H.R. 8529: Protecting Access to Affordable Medicines Act of 2020](https://openamerica.io/bill/116-HR-8529/)